Based on the QIAGEN NV stock forecast from 0 analysts, the average analyst target price for QIAGEN NV is not available over the next 12 months. QIAGEN NV’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of QIAGEN NV is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, QIAGEN NV’s stock price was EUR 40.20. QIAGEN NV’s stock price has changed by -0.12% over the past week, -2.98% over the past month and -71.75% over the last year.
No recent analyst target price found for QIAGEN NV
No recent average analyst rating found for QIAGEN NV
Company Overview QIAGEN NV
Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID and forensics assay consumables, such as STR assays for human ID, and assays for food contamination; PCR instruments include digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It also offers predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a collaboration with the U.S. FBI; and with Bio-Manguinhos/Fiocruz to detect malaria and dengue. The company was founded in 1984 and is headquartered in Venlo, the Netherlands. Read Less
Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and purification kits for sample materials, manual and automated processing for genotyping...Read More
Frequently Asked Questions About QIAGEN NV (QIA:F) Stock
Stock Target Advisor's fundamental analysis for QIAGEN NV's stock is Neutral.
QIA:F stock's dividend yield is 2.91%.
Our analysis grades QIA:F stock's dividend yield at C. This means that QIA:F stock's dividend yield is above 73% of the stocks in the Diagnostics & Research sector in the F exchange.
Based on this QIA:F may be a average dividend stock for its sector.
Unfortunately we do not have enough data on QIA:F's stock to indicate what its average analyst target is.
QIA:F stock's Price/Earning ratio is 126.20.
Our analysis grades QIA:F stock's Price / Earning ratio at F. This means that QIA:F stock's Price/Earning ratio is above 84% of the stocks in the Diagnostics & Research sector in the F exchange.
Based on this QIA:F may be a overvalued for its sector.
The last closing price of QIA:F's stock was EUR 40.20.
The most recent market capitalization for QIA:F is EUR 9.01B.
Unfortunately we do not have enough analyst data on QIA:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains QIAGEN NV's stock.
As per our most recent records QIAGEN NV has 5,900 Employees.
QIAGEN NV's registered address is Hulsterweg 82, Venlo, Netherlands, 5912 PL.
You can get more information about it from QIAGEN NV's website at https://www.qiagen.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About QIAGEN NV (QIA:F) Stock
Stock Target Advisor's fundamental analysis for QIAGEN NV's stock is Neutral.
QIA:F stock's dividend yield is 2.91%.
Our analysis grades QIA:F stock's dividend yield at C. This means that QIA:F stock's dividend yield is above 73% of the stocks in the Diagnostics & Research sector in the F exchange.
Based on this QIA:F may be a average dividend stock for its sector.
Unfortunately we do not have enough data on QIA:F's stock to indicate what its average analyst target is.
QIA:F stock's Price/Earning ratio is 126.20.
Our analysis grades QIA:F stock's Price / Earning ratio at F. This means that QIA:F stock's Price/Earning ratio is above 84% of the stocks in the Diagnostics & Research sector in the F exchange.
Based on this QIA:F may be a overvalued for its sector.
The last closing price of QIA:F's stock was EUR 40.20.
The most recent market capitalization for QIA:F is EUR 9.01B.
Unfortunately we do not have enough analyst data on QIA:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains QIAGEN NV's stock.
As per our most recent records QIAGEN NV has 5,900 Employees.
QIAGEN NV's registered address is Hulsterweg 82, Venlo, Netherlands, 5912 PL.
You can get more information about it from QIAGEN NV's website at https://www.qiagen.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for QIA:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
